DRUG ENFORCEMENT ADMINISTRATION related term(s) Department of Justice

Affidavits

Affadavit of William Julié, E1082 [25OC]

Amendments

Drugs: decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), H4106, H4107, H4108 [1AP]

——— decriminalize, expunge prior convictions, tax products to create programs for those hurt by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), consideration (H. Res. 1017), H4031 [31MR]

——— streamline, coordinate and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (S. 253), S1781 [24MR]

Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: extend (S. 1216), S955 [2MR]

Articles and editorials

Cannabis Liberalization in the US—The Policy Landscape, H4103–H4105 [1AP]

Bills and resolutions

Controlled Substances Act: amend to fix technical error in definitions (see S. 4235), S2544 [17MY] (see H.R. 9178), H8395 [14OC]

Courts: establish appropriate penalties for cocaine-related offenses (see S. 4116), S2219 [28AP]

Crime: provide for life imprisonment for certain offenses involving fentanyl (see H.R. 6439), H288 [20JA]

Dept. of Justice: register practitioners to transport controlled substances to States in which practitioner is not registered to administer substances at places outside of principal places of business (see H.R. 7259), H3895 [28MR]

——— require electronic communication service providers and remote computing services to report unlawful sale and distribution of counterfeit substances and certain controlled substances (see S. 5297), S7311 [19DE]

Drugs: codify temporary scheduling order for fentanyl-related substances by adding fentanyl-related substances to schedule I of Controlled Substances Act (see S. 3457), S118 [10JA]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (see S. 4591), S3611 [21JY]

——— decriminalize, expunge prior convictions, tax products to create programs for those hurt by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), consideration (see H. Res. 1017), H4071 [31MR]

——— direct President to provide documents to House of Representatives relative to communications with several agencies on recommendations to reduce availability of illicitly manufactured fentanyl-related substances (see H. Res. 1274), H7170 [26JY]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (see H.R. 6946), H1328 [7MR]

——— increase number of cannabis manufacturers registered under Controlled Substances Act for legitimate research purposes and allow VA health care providers to recommend federally-approved cannabis clinical trials (see H.R. 9679), H10055 [22DE]

——— make permanent scheduling of fentanyl-related substances (see H.R. 6713), H1119 [11FE]

——— prohibit deceptive sale of fentanyl (see S. 4984), S5225 [28SE]

——— require removal of drug from scheduling within certain period pursuant to recommendation of Dept. of HHS (see H.R. 8931), H8064 [21SE]

——— streamline, coordinate, and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (see H.R. 8454), H7065 [21JY]

FDA: protect access to kratom (see S. 5316), S9625 [20DE] (see H.R. 9634), H9909 [20DE]

Research: modify registration requirements relative to research with controlled substances (see S. 5123), S6779 [17NO]

Science, Depts. of Justice and Commerce, and related agencies: making appropriations (see S. 4664), S3782 [28JY] (see H.R. 8256), H5929 [1JY]

Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: extend (see S. 5167), S6941 [1DE] (see H.R. 9595), H9902 [15DE]

Letters

Countering Assad’s Proliferation Trafficking and Garnering of Narcotics (CAPTAGON) Act: Representative Meeks, Committee on Foreign Affairs (House), H7907 [19SE]

——— Representative Nadler, Committee on the Judiciary (House), H7907 [19SE]

Marijuana Opportunity Reinvestment and Expungement (MORE) Act: several organizations, H4105 [1AP]

Medical Marijuana Research Act: Representative Nadler, Committee on the Judiciary (House), E371 [7AP]

——— Representative Pallone, Committee on Energy and Commerce (House), E371 [7AP]

Request Dept. of State review and determine whether Syria meets criteria to be defined as ‘‘major illicit drug producing country’’ or ‘‘major drug-transit country’’: Representatives Hill and Boyle and Senator Marshall, H7907 [19SE]

Lists

Votes recorded by proxy on H. Res. 1017, consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4033 [31MR]

Votes recorded by proxy on H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4115 [1AP]

Votes recorded by proxy on H.R. 5657, Medical Marijuana Research Act, H4144 [4AP]

Votes recorded by proxy on H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, H7146 [26JY]

Votes recorded by proxy on Latta motion to recommit H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4115 [1AP]

Votes recorded by proxy on previous question to H. Res. 1017, consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4032 [31MR]

Motions

Drugs: decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), H4112 [1AP]

Notices

Estimated budget effects of H.R. 5657, Medical Marijuana Research Act, H4152 [4AP]

Estimated budget effects of H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, H7163 [26JY]

Remarks in House

Crime: provide for life imprisonment for certain offenses involving fentanyl (H.R. 6439), H901 [2FE], H1063 [8FE]

Drugs: clarify process for registrants to exercise due diligence upon discovering suspicious orders, H5791 [22JN]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), H3973 [30MR], H4078–H4116, H4119 [1AP], H4147 [4AP], H4160 [5AP]

——— decriminalize, expunge prior convictions, tax products to create programs for those hurt by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), consideration (H. Res. 1017), H4023–H4033 [31MR]

——— delay implementation of separate registration requirement for dispensing narcotic drugs categorized in schedules with lower potential for abuse that are intended for maintenance or detoxification treatment, H5793–H5795 [22JN]

——— eliminate separate registration requirement for dispensing narcotic drugs categorized in schedules with lower potential for abuse that are intended for maintenance or detoxification treatment, H5777 [22JN]

——— improve medical research on marijuana by simplifying registration process to conduct research, facilitating access for such research, and allowing private manufacture and distribution for research purposes (H.R. 5657), H4136–H4140 [4AP]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (H.R. 6946), H7886 [19SE]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (S. 339), H39 [11JA]

——— make permanent scheduling of fentanyl-related substances (H.R. 6184), H352, H353, H901, H902, H903 [2FE], H979, H982 [7FE], H1021, H1062 [8FE], H4094 [1AP], H8083 [22SE], H8174–H8177 [28SE]

——— streamline, coordinate, and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (H.R. 8454), H7120–H7124 [26JY]

Law enforcement: authority to perform arrests or detainments in foreign countries, E591 [8JN], E1081 [25OC]

Red Ribbon Week: observance, E1049 [14OC]

Science, Depts. of Justice and Commerce, and related agencies: making appropriations, H1410, H1411 [9MR]

Syria: require U.S. strategy to disrupt and dismantle Captagon trade and narcotics networks linked to regime of Bashar al-Assad, H9849 [14DE]

——— require U.S. strategy to disrupt and dismantle Captagon trade and narcotics networks linked to regime of Bashar al-Assad (H.R. 6265), H7906–H7908 [19SE], H7984 [20SE]

Remarks in Senate

Controlled Substances Act: amend to fix technical error in definitions (S. 4235), S4624 [14SE]

Drugs: codify temporary scheduling order for fentanyl-related substances by adding fentanyl-related substances to schedule I of Controlled Substances Act (S. 3457), S120 [10JA], S272 [18JA]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (S. 4591), S3581 [21JY]

——— decriminalize marijuana at Federal level and provide for taxation and regulation of marijuana products, S620 [10FE]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (S. 1006), S5135–S5137 [28SE]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (S. 1006), unanimous-consent request, S5136, S5137 [28SE]

——— prohibit deceptive sale of fentanyl (S. 4984), S5130, S5131 [28SE]

——— prohibit deceptive sale of fentanyl (S. 4984), unanimous-consent request, S5130, S5131 [28SE]

——— streamline, coordinate, and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (H.R. 8454), S6736, S6746 [16NO]

——— streamline, coordinate and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (S. 253), S1784 [24MR]

Honduras: recognize anniversary of massacre of Ahuas villagers by DEA officers during counternarcotics operations and urge accountability for efforts to misrepresent facts and obstruct resulting investigation, S2445 [11MY]

Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: extend (S. 1216), S928–S930 [2MR], S4892 [21SE], S5137 [28SE]

——— extend (S. 1216), unanimous-consent request, S928, S929 [2MR], S5137 [28SE]

Reports filed

Consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act: Committee on Rules (House) (H. Res. 1017) (H. Rept. 117–285), H4071 [31MR]

Direct President To Provide Documents With Several Agencies on Recommendations To Reduce Availability of Illicitly Manufactured Fentanyl-Related Substances: Committee on Energy and Commerce (House) (H. Res. 1274) (H. Rept. 117–527), H8313 [29SE]

Marijuana Opportunity Reinvestment and Expungement (MORE) Act: Committee on the Judiciary (House) (H.R. 3617) (H. Rept. 117–276), H3862 [24MR]

Science, Depts. of Justice and Commerce, and Related Agencies Appropriations: Committee on Appropriations (House) (H.R. 8256) (H. Rept. 117–395), H5929 [1JY]

Texts of

H. Res. 1017, consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4023 [31MR]

H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4079–H4087 [1AP]

H.R. 5657, Medical Marijuana Research Act, H4136–H4138 [4AP]

H.R. 6265, Countering Assad’s Proliferation Trafficking and Garnering of Narcotics (CAPTAGON) Act, H7906 [19SE], H7985 [20SE]

H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, H7120–H7122 [26JY]

S. 4235, amend Controlled Substances Act to fix technical error in definitions, S4625 [14SE]